Stock Screener · Library
Vaxcyte, Inc. financial statement history
Source-linked financial facts for Vaxcyte, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 324337000 | USD | 2023-02-27 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-004654 |
| As of 2022-12-31 | 1006178000 | USD | 2024-02-27 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-021145 |
| As of 2023-12-31 | 1407917000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Assets | 10-K · 0001649094-25-000028 |
| As of 2024-12-31 | 3511318000 | USD | 2026-02-24 | 2025 / FY | us-gaap:Assets | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 3002717000 | USD | 2026-02-24 | 2025 / FY | us-gaap:Assets | 10-K · 0001649094-26-000007 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 256348000 | USD | 2023-02-27 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-004654 |
| As of 2022-12-31 | 942555000 | USD | 2024-02-27 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-021145 |
| As of 2023-12-31 | 1095954000 | USD | 2025-02-25 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001649094-25-000028 |
| As of 2024-12-31 | 1787985000 | USD | 2026-02-24 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 1627361000 | USD | 2026-02-24 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001649094-26-000007 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 68985000 | USD | 2023-02-27 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-004654 |
| As of 2022-12-31 | 834657000 | USD | 2025-02-25 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001649094-25-000028 |
| As of 2023-12-31 | 397451000 | USD | 2026-02-24 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001649094-26-000007 |
| As of 2024-12-31 | 387878000 | USD | 2026-02-24 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 173959000 | USD | 2026-02-24 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001649094-26-000007 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 7954000 | USD | 2023-02-27 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-004654 |
| As of 2022-12-31 | 10360000 | USD | 2024-02-27 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-021145 |
| As of 2023-12-31 | 79626000 | USD | 2025-02-25 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001649094-25-000028 |
| As of 2024-12-31 | 198045000 | USD | 2026-02-24 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 257370000 | USD | 2026-02-24 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001649094-26-000007 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 40319000 | USD | 2023-02-27 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-004654 |
| As of 2022-12-31 | 52565000 | USD | 2024-02-27 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-021145 |
| As of 2023-12-31 | 167449000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001649094-25-000028 |
| As of 2024-12-31 | 205499000 | USD | 2026-02-24 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 317207000 | USD | 2026-02-24 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001649094-26-000007 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 28716000 | USD | 2023-02-27 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-004654 |
| As of 2022-12-31 | 40525000 | USD | 2024-02-27 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-021145 |
| As of 2023-12-31 | 145338000 | USD | 2025-02-25 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001649094-25-000028 |
| As of 2024-12-31 | 140180000 | USD | 2026-02-24 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 205750000 | USD | 2026-02-24 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001649094-26-000007 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 284018000 | USD | 2025-02-25 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001649094-25-000028 |
| As of 2022-12-31 | 953613000 | USD | 2026-02-24 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001649094-26-000007 |
| As of 2023-12-31 | 1240468000 | USD | 2026-02-24 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001649094-26-000007 |
| As of 2024-12-31 | 3305819000 | USD | 2026-02-24 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001649094-26-000007 |
| As of 2025-12-31 | 2685510000 | USD | 2026-02-24 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001649094-26-000007 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 78411000 | USD | 2024-02-27 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-021145 |
| 2022-01-01 to 2022-12-31 | 169451000 | USD | 2025-02-25 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001649094-25-000028 |
| 2023-01-01 to 2023-12-31 | 332341000 | USD | 2026-02-24 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001649094-26-000007 |
| 2024-01-01 to 2024-12-31 | 476644000 | USD | 2026-02-24 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001649094-26-000007 |
| 2025-01-01 to 2025-12-31 | 794306000 | USD | 2026-02-24 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001649094-26-000007 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -103670000 | USD | 2024-02-27 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-021145 |
| 2022-01-01 to 2022-12-31 | -232256000 | USD | 2025-02-25 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001649094-25-000028 |
| 2023-01-01 to 2023-12-31 | -468041000 | USD | 2026-02-24 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001649094-26-000007 |
| 2024-01-01 to 2024-12-31 | -569546000 | USD | 2026-02-24 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001649094-26-000007 |
| 2025-01-01 to 2025-12-31 | -923675000 | USD | 2026-02-24 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001649094-26-000007 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -100077000 | USD | 2024-02-27 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-021145 |
| 2022-01-01 to 2022-12-31 | -223485000 | USD | 2025-02-25 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001649094-25-000028 |
| 2023-01-01 to 2023-12-31 | -402266000 | USD | 2026-02-24 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001649094-26-000007 |
| 2024-01-01 to 2024-12-31 | -463927000 | USD | 2026-02-24 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001649094-26-000007 |
| 2025-01-01 to 2025-12-31 | -766628000 | USD | 2026-02-24 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001649094-26-000007 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -1.93 | USD/shares | 2024-02-27 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-24-021145 |
| 2022-01-01 to 2022-12-31 | -3.44 | USD/shares | 2025-02-25 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001649094-25-000028 |
| 2023-01-01 to 2023-12-31 | -4.14 | USD/shares | 2026-02-24 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001649094-26-000007 |
| 2024-01-01 to 2024-12-31 | -3.8 | USD/shares | 2026-02-24 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001649094-26-000007 |
| 2025-01-01 to 2025-12-31 | -5.63 | USD/shares | 2026-02-24 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001649094-26-000007 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -121393000 | USD | 2024-02-27 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-021145 |
| 2022-01-01 to 2022-12-31 | -170597000 | USD | 2025-02-25 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001649094-25-000028 |
| 2023-01-01 to 2023-12-31 | -296790000 | USD | 2026-02-24 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001649094-26-000007 |
| 2024-01-01 to 2024-12-31 | -452627000 | USD | 2026-02-24 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001649094-26-000007 |
| 2025-01-01 to 2025-12-31 | -655577000 | USD | 2026-02-24 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001649094-26-000007 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 6555000 | USD | 2024-02-27 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-24-021145 |
| 2022-01-01 to 2022-12-31 | 5841000 | USD | 2025-02-25 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001649094-25-000028 |
| 2023-01-01 to 2023-12-31 | 16062000 | USD | 2026-02-24 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001649094-26-000007 |
| 2024-01-01 to 2024-12-31 | 22427000 | USD | 2026-02-24 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001649094-26-000007 |
| 2025-01-01 to 2025-12-31 | 13713000 | USD | 2026-02-24 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001649094-26-000007 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1649094
- Ticker in native snapshot
- PCVX
- Reported numeric facts
- 65
- Units present
- USD · USD/shares